Literature DB >> 12818808

In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations.

Sheng-Fang Su1, Chen-Hsi Chou, Chao-Feng Kung, Jin-ding Huang.   

Abstract

The aim of this study was to investigate the effect of formulation on the pharmacokinetics of diclofenac in two sustained release formulations (formulation A and Voltaren SR) after oral delivery. The dissolution of diclofenac from sustained release formulation was pH-dependent. While drug released from both formulations increased with increased pH, the release kinetics of these two formulations was different. The pharmacokinetic study was conducted in 12 healthy subjects administered with multiple doses of 100mg of diclofenac in a crossover design. There was a significant difference in area under the plasma concentration-time curve [AUC(0-24)] and C(max) observed. The formulation with a reduced diffusion exponent with increased kinetic constant results in increased absorption of diclofenac in vivo. This study demonstrated the impact of release mechanism of the formulation on the absorption in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818808     DOI: 10.1016/s0378-5173(03)00237-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Oxycellulose beads with drug exhibiting pH-dependent solubility.

Authors:  Martina Bajerová; Kateřina Krejčová; Miloslava Rabišková; Jan Muselík; Kateřina Dvořáčková; Jan Gajdziok; Ruta Masteiková
Journal:  AAPS PharmSciTech       Date:  2011-10-18       Impact factor: 3.246

2.  Evaluation of Mimosa pudica seed mucilage as sustained-release excipient.

Authors:  Kuldeep Singh; Ashok Kumar; Naresh Langyan; Munish Ahuja
Journal:  AAPS PharmSciTech       Date:  2009-09-18       Impact factor: 3.246

3.  Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.

Authors:  Luiz F Zerbini; Rodrigo E Tamura; Ricardo G Correa; Akos Czibere; Jason Cordeiro; Manoj Bhasin; Fernando M Simabuco; Yihong Wang; Xuesong Gu; Linglin Li; Devanand Sarkar; Jin-Rong Zhou; Paul B Fisher; Towia A Libermann
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

4.  Release kinetics of papaverine hydrochloride from tablets with different excipients.

Authors:  Regina Kasperek; Andrzej Polski; Łukasz Zimmer; Ewa Poleszak
Journal:  Sci Pharm       Date:  2014-05-16

Review 5.  Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.

Authors:  Roy Altman; Bill Bosch; Kay Brune; Paola Patrignani; Clarence Young
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

6.  Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.

Authors:  Pan Pantziarka; Vidula Sukhatme; Gauthier Bouche; Lydie Meheus; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-01-11

7.  Formulation and pharmacokinetics of multi-layered matrix tablets: Biphasic delivery of diclofenac.

Authors:  Ehab Mostafa Elzayat; Ali Abdelzaher Abdel-Rahman; Sayed Mohamed Ahmed; Fars Kaed Alanazi; Walid Abdulazim Habib; Hisham Suliman Abou-Auda; Adel Sakr
Journal:  Saudi Pharm J       Date:  2016-10-17       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.